YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Epilepsy Drugs
Another Valproate Study Sees Problems for Developing Fetus
Jul 22, 2009 | Parker Waichman Alonso LLP
Children exposed to valproate in-utero may exhibit lower IQs as toddlers than children whose mothers took other epilepsy drugs, according to...
Suicide Warnings Approved for Epilepsy Drugs
May 6, 2009 | Parker Waichman Alonso LLP
Federal regulators have approved new suicide warnings for more than two dozen epilepsy drugs. The Food & Drug Administration (FDA) had...
Valproate Shouldn't be Taken by Pregnant Women, Medical Groups Say
Apr 28, 2009 | Parker Waichman Alonso LLP
The epilepsy drug valproate (Depacon) should not be taken by pregnant women, according to new guidelines issued by American Academy of Neurology and...
Valproate During Pregnancy Linked to Children with Lower IQs
Apr 16, 2009 | Parker Waichman Alonso LLP
Valproate (sold under the brand names Depacon and Depakene) taken during pregnancy may cause children to have lower IQs, according to a new study...
Zonegran Linked to Blood Disorder
Feb 23, 2009 | Parker Waichman Alonso LLP
The epilepsy drug zonisamide, sold both generically and under the brand name Zonegran, can cause a serious blood disorder called metabolic acidosis,...
Valproate Use During Pregnancy Linked to Autism
Dec 2, 2008 | Parker Waichman Alonso LLP
Mothers who take the epilepsy drug valproate (sold under the brand names Depacon and Depakene) during pregnancy may face an increased risk of having...
Advisory Panel Rejects 'Black Box' Warnings of Suicide Risk on Epilepsy Drugs
Jul 11, 2008 | Parker Waichman Alonso LLP
An expert advisory panel refused a Food & Drug Administration (FDA) proposal to place a “Black Box”—the agency’s...
Epilepsy Drugs Targeted for Black Box Suicide Warning
Jul 8, 2008 | Parker Waichman Alonso LLP
Federal regulators want the makers of epilepsy drugs to add a black box warning to their labels about their association with suicidal thoughts and...
Neurontin Should Have Had Depression Warning, Neurologist Says
Jun 20, 2008 | Parker Waichman Alonso LLP
A British neurologist says he advised the maker of Neurontin to include a warning on its label about its potential to cause depression and...
New Suicide Warning for Epilepsy Drugs
Jun 12, 2008 | Parker Waichman Alonso LLP
United States drug reviewers just announced that epilepsy drugs are associated with a higher risk of suicidal thoughts and behavior. The...
Defective Drugs
